Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Inotiv Inc NOTV

Inotiv, Inc. is a contract research company, which is engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices... see more

Recent & Breaking News (NDAQ:NOTV)

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Inotiv, Inc. with Losses of $100,000 to Contact the Firm

Business Wire May 26, 2022

INOTIV ALERT: Bragar Eagel & Squire, P.C. is Investigating Inotiv, Inc. on Behalf of Inotiv Stockholders and Encourages Investors to Contact the Firm

Business Wire May 25, 2022

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Inotiv, Inc. with Losses of $100,000 to Contact the Firm

Business Wire May 25, 2022

INOTIV ALERT: Bragar Eagel & Squire, P.C. is Investigating Inotiv, Inc. on Behalf of Inotiv Stockholders and Encourages Investors to Contact the Firm

Business Wire May 24, 2022

Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of Inotiv, Inc. (NOTV) Investors

Business Wire May 24, 2022

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Inotiv, Inc. (NOTV) on Behalf of Investors

Business Wire May 24, 2022

EQUITY ALERT: Rosen Law Firm Encourages Inotiv, Inc. Investors with Losses to Inquire About Class Action Investigation - NOTV

Business Wire May 24, 2022

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Inotiv, Inc. (NOTV) on Behalf of Investors

Business Wire May 24, 2022

The Law Offices of Frank R. Cruz Announces Investigation of Inotiv, Inc. (NOTV) on Behalf of Investors

Business Wire May 23, 2022

Inotiv, Inc. to Participate in Upcoming Investor Conferences

GlobeNewswire May 16, 2022

Inotiv, Inc. Announces Second Quarter Fiscal 2022 Financial Results

GlobeNewswire May 12, 2022

Inotiv, Inc. to Report Second Quarter Fiscal 2022 Financial Results and Host Conference Call on Thursday, May 12, 2022

GlobeNewswire April 26, 2022

Inotiv, Inc. Bolsters Pathology Services with Acquisition of Histion, LLC

GlobeNewswire April 25, 2022

Inotiv, Inc. Announces First Quarter Fiscal 2022 Financial Results

GlobeNewswire February 10, 2022

Inotiv, Inc. to Report First Quarter Fiscal 2022 Financial Results and Host Conference Call on Thursday, February 10, 2022

GlobeNewswire January 27, 2022

Inotiv, Inc. Announces Expansion of Non-Human Primate Facilities and Services with Acquisition of Orient BioResource Center, Inc.

GlobeNewswire January 27, 2022

Inotiv, Inc. Announces Expansion of Safety Assessment Offerings with Acquisition of Integrated Laboratory Systems, LLC

GlobeNewswire January 10, 2022

Inotiv, Inc. Announces the Acquisition of the Rabbit Breeding and Supply Business of Robinson Services Inc. ("RSI")

GlobeNewswire January 6, 2022

Inotiv, Inc. and Synexa Life Sciences Sign Letter of Intent to Establish Center of Excellence for Biotherapeutics and Biomarkers

GlobeNewswire January 4, 2022

Inotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2021 Financial Results

GlobeNewswire December 16, 2021